T

Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM

Watchlist Manager
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Watchlist
Price: 3 167.1 INR 2.1% Market Closed
Market Cap: 1.1T INR
Have any thoughts about
Torrent Pharmaceuticals Ltd?
Write Note

Intrinsic Value

The intrinsic value of one TORNTPHARM stock under the Base Case scenario is 1 952.77 INR. Compared to the current market price of 3 167.1 INR, Torrent Pharmaceuticals Ltd is Overvalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TORNTPHARM Intrinsic Value
1 952.77 INR
Overvaluation 38%
Intrinsic Value
Price
T
Worst Case
Base Case
Best Case

Valuation Backtest
Torrent Pharmaceuticals Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for TORNTPHARM cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about TORNTPHARM?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Torrent Pharmaceuticals Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Torrent Pharmaceuticals Ltd

Provide an overview of the primary business activities
of Torrent Pharmaceuticals Ltd.

What unique competitive advantages
does Torrent Pharmaceuticals Ltd hold over its rivals?

What risks and challenges
does Torrent Pharmaceuticals Ltd face in the near future?

Has there been any significant insider trading activity
in Torrent Pharmaceuticals Ltd recently?

Summarize the latest earnings call
of Torrent Pharmaceuticals Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Torrent Pharmaceuticals Ltd.

Provide P/S
for Torrent Pharmaceuticals Ltd.

Provide P/E
for Torrent Pharmaceuticals Ltd.

Provide P/OCF
for Torrent Pharmaceuticals Ltd.

Provide P/FCFE
for Torrent Pharmaceuticals Ltd.

Provide P/B
for Torrent Pharmaceuticals Ltd.

Provide EV/S
for Torrent Pharmaceuticals Ltd.

Provide EV/GP
for Torrent Pharmaceuticals Ltd.

Provide EV/EBITDA
for Torrent Pharmaceuticals Ltd.

Provide EV/EBIT
for Torrent Pharmaceuticals Ltd.

Provide EV/OCF
for Torrent Pharmaceuticals Ltd.

Provide EV/FCFF
for Torrent Pharmaceuticals Ltd.

Provide EV/IC
for Torrent Pharmaceuticals Ltd.

Show me price targets
for Torrent Pharmaceuticals Ltd made by professional analysts.

What are the Revenue projections
for Torrent Pharmaceuticals Ltd?

How accurate were the past Revenue estimates
for Torrent Pharmaceuticals Ltd?

What are the Net Income projections
for Torrent Pharmaceuticals Ltd?

How accurate were the past Net Income estimates
for Torrent Pharmaceuticals Ltd?

What are the EPS projections
for Torrent Pharmaceuticals Ltd?

How accurate were the past EPS estimates
for Torrent Pharmaceuticals Ltd?

What are the EBIT projections
for Torrent Pharmaceuticals Ltd?

How accurate were the past EBIT estimates
for Torrent Pharmaceuticals Ltd?

Compare the revenue forecasts
for Torrent Pharmaceuticals Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Torrent Pharmaceuticals Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Torrent Pharmaceuticals Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Torrent Pharmaceuticals Ltd compared to its peers.

Compare the P/E ratios
of Torrent Pharmaceuticals Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Torrent Pharmaceuticals Ltd with its peers.

Analyze the financial leverage
of Torrent Pharmaceuticals Ltd compared to its main competitors.

Show all profitability ratios
for Torrent Pharmaceuticals Ltd.

Provide ROE
for Torrent Pharmaceuticals Ltd.

Provide ROA
for Torrent Pharmaceuticals Ltd.

Provide ROIC
for Torrent Pharmaceuticals Ltd.

Provide ROCE
for Torrent Pharmaceuticals Ltd.

Provide Gross Margin
for Torrent Pharmaceuticals Ltd.

Provide Operating Margin
for Torrent Pharmaceuticals Ltd.

Provide Net Margin
for Torrent Pharmaceuticals Ltd.

Provide FCF Margin
for Torrent Pharmaceuticals Ltd.

Show all solvency ratios
for Torrent Pharmaceuticals Ltd.

Provide D/E Ratio
for Torrent Pharmaceuticals Ltd.

Provide D/A Ratio
for Torrent Pharmaceuticals Ltd.

Provide Interest Coverage Ratio
for Torrent Pharmaceuticals Ltd.

Provide Altman Z-Score Ratio
for Torrent Pharmaceuticals Ltd.

Provide Quick Ratio
for Torrent Pharmaceuticals Ltd.

Provide Current Ratio
for Torrent Pharmaceuticals Ltd.

Provide Cash Ratio
for Torrent Pharmaceuticals Ltd.

What is the historical Revenue growth
over the last 5 years for Torrent Pharmaceuticals Ltd?

What is the historical Net Income growth
over the last 5 years for Torrent Pharmaceuticals Ltd?

What is the current Free Cash Flow
of Torrent Pharmaceuticals Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Torrent Pharmaceuticals Ltd.

Business Breakdown

Torrent Pharmaceuticals Ltd. has steadily carved a niche for itself as a formidable player in the global pharmaceutical landscape. Founded in 1959 in India, the company specializes in developing, manufacturing, and marketing a diverse portfolio of generic and branded formulations across therapeutic areas such as cardiovascular, central nervous system, and diabetology, among others. With a robust presence in over 40 countries and a strong focus on research and development, Torrent has established partnerships and collaborations that bolster its ability to innovate and expand its product offerings. The company’s commitment to quality and regulatory compliance is evident as it operates multiple...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Torrent Pharmaceuticals Ltd

Current Assets 58.8B
Cash & Short-Term Investments 14.8B
Receivables 17.9B
Other Current Assets 26.1B
Non-Current Assets 92.1B
Long-Term Investments 650m
PP&E 36.3B
Intangibles 46.7B
Other Non-Current Assets 8.4B
Current Liabilities 48.5B
Accounts Payable 21.9B
Other Current Liabilities 26.6B
Non-Current Liabilities 27.4B
Long-Term Debt 14.7B
Other Non-Current Liabilities 12.6B
Efficiency

Earnings Waterfall
Torrent Pharmaceuticals Ltd

Revenue
112.2B INR
Cost of Revenue
-27.5B INR
Gross Profit
84.8B INR
Operating Expenses
-56.9B INR
Operating Income
27.8B INR
Other Expenses
-9.8B INR
Net Income
18B INR

Free Cash Flow Analysis
Torrent Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q2 FY25, Torrent Pharma reported a 9% revenue growth to INR 2,889 crores, with branded businesses driving 74% of revenue. Notably, the India segment saw a healthier 13% growth. Operating EBITDA rose by 14% to INR 939 crores, yielding a margin of 32.5%. The company anticipates recovery of insulin revenue shortfall in Q4, ensuring no annual impact. Looking ahead, Torrent expects a sustainable EBITDA margin improvement of 50-100 basis points annually and aims for continued double-digit growth in Brazil. However, U.S. revenue growth remains modest, projected to stabilize in the coming years with profitability targeted within three years.

What is Earnings Call?
Fundamental Scores

TORNTPHARM Profitability Score
Profitability Due Diligence

Torrent Pharmaceuticals Ltd's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive Operating Income
65/100
Profitability
Score

Torrent Pharmaceuticals Ltd's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

TORNTPHARM Solvency Score
Solvency Due Diligence

Torrent Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Negative Net Debt
67/100
Solvency
Score

Torrent Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TORNTPHARM Price Targets Summary
Torrent Pharmaceuticals Ltd

Wall Street analysts forecast TORNTPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TORNTPHARM is 3 552.51 INR with a low forecast of 2 385.62 INR and a high forecast of 4 236.75 INR.

Lowest
Price Target
2 385.62 INR
25% Downside
Average
Price Target
3 552.51 INR
12% Upside
Highest
Price Target
4 236.75 INR
34% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for TORNTPHARM?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for TORNTPHARM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

TORNTPHARM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Torrent Pharmaceuticals Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

1.1T INR

Dividend Yield

0.88%

Description

Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. The company is headquartered in Ahmedabad, Gujarat and currently employs 12,910 full-time employees. The firm is engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. The company operates in the therapeutic segments of cardiovascular (CV), gastrointestinal (GI), central nervous system (CNS), and vitamins minerals nutritionals (VMN). The company also has presence in therapeutic areas, such as anti-epileptic, anti-diabetic, anti-cancer, anti-acne, corticosteroids and cosmeceuticals. The company has developed complex formulations for global markets based on oral solids, injections, inhalation technologies, long-acting depot injections ophthalmic, nasal, semisolids for external applications and multi-particulate extended-release oral systems. The firm is developing various in-house new chemical entities (NCE) in the areas of metabolic, cardiovascular, gastrointestinal, dermatological and respiratory disorders. The company has a presence across more than 40 countries.

Contact

GUJARAT
Ahmedabad
Torrent House, Off. Ashram Road
+917926599000
www.torrentpharma.com

IPO

1994-11-03

Employees

12 910

Officers

Executive Chairman & MD
Mr. Samir Uttamlal Mehta B.Com., MBA
Whole-Time Director
Mr. Aman Mehta
Chief Financial Officer
Mr. Sudhir Menon CA, CWA
Company Secretary & Compliance Officer
Mr. Chintan M. Trivedi
Vice President of Human Resource
Mr. Jaydip Bhatt
Executive Director
Mr. Ashish Hajarnish M.Pharm
Show More
Chief Customer Service Officer
Mr. Abdullah Salam Said Al Abri
Show Less

See Also

Discover More
What is the Intrinsic Value of one TORNTPHARM stock?

The intrinsic value of one TORNTPHARM stock under the Base Case scenario is 1 952.77 INR.

Is TORNTPHARM stock undervalued or overvalued?

Compared to the current market price of 3 167.1 INR, Torrent Pharmaceuticals Ltd is Overvalued by 38%.

Back to Top